Reedland Capital Partners


Our Team Our senior management team is comprised of professionals and experienced executives with extensive records of performance in a diverse range of industries. We are extremely client-oriented and each of our client companies is always represented and serviced directly by one of the highly experienced managing principals of our firm. Robert K. Schacter, Founder/President Jason E. Cohen David M. Schachter Sanford Zweifach
Robert K. Schacter, Founder/President Mr. Schacter is a founder of the firm and brings with him over 20 years of investment banking and securities industry experience. Prior to forming Reedland in 1998, Mr. Schacter began his investment career in 1983 at Paine Webber, Inc., where he became one of the youngest satellite office managers in the firm's history, assisted with private placement transactions for a number of the country's pioneer biotechnology companies and traded those securities for his clients in the secondary market. In 1986, Mr. Schacter joined Smith Barney, Harris Upham & Co. as Vice President of Retail Sales. Four years later, he joined Wharton Capital as Senior Vice President, where he was responsible for securing secondary debt and raising equity capital for oil and gas industry companies. In 1991, Mr. Schacter became Vice President of Sales at Lehman Brothers, where he was responsible for servicing and managing institutional bond accounts. Prior to forming Reedland in 1998, Rob was a Managing Director at Shoreline Pacific Institutional Finance, where he was responsible for originating and helping structure & negotiate more than $750 million in private equity financings for publicly-listed emerging growth companies. ^ Return to Top


	David M. Schachter Mr. Schachter heads Reedland's investment banking group with respect to debt-based transactions and is a nationally recognized expert in advising client companies on corporate and commercial real estate debt transactions. Reedland Capital structures, arranges and negotiates senior credit facilities, mezzanine debt and bridge loans for both publicly traded and privately-held companies in most industries. Loan size typically ranges from $20 million to $200 million and proceeds can be used for growth capital, acquisitions or refinancing of existing debt on more favorable terms such as less onerous covenants, better pricing and/or greater availability. Mr. Schachter has established extensive relationships, both in the United States and abroad, with commercial banks, asset-based lenders, and cash flow-based lenders, many of which are non-traditional sources of capital that can provide more flexibility to companies from a pricing, structure and availability standpoint. With capital severely constrained today, Mr. Schachter and the other members of his group can be a valuable tool in restructuring a company's balance sheet to facilitate greater profitability. Prior to joining Reedland upon its inception in early 1998, Mr. Schachter was a securities and financial institutions transactional attorney for over 12 years (initially with Pillsbury, Madison & Sutro and then as a partner at a boutique firm based in Los Angeles that specialized in representing financial institutions and broker-dealers). In that capacity, he developed extensive experience in negotiating various types of complex equity and debt financings, loan workouts as well as structuring and negotiating asset disposition transactions with the Resolution Trust Corporation. Mr. Schachter received an M.B.A. degree in corporate finance from the University of San Diego School of Business, where he graduated magna cum laude and a JD degree from the University of San Diego School of Law where he graduated cum laude and was a member of the USD Law Review. Mr. Schachter is also a Series 24 General Securities Principal. ^ Return to Top

Sanford Zweifach Mr. Zweifach joined Reedland in 2005 and heads our life sciences M&A/advisory efforts, bringing with him 15 years of proven experience in investment banking, investing, business development, mergers & acquisitions, and management. Prior to joining Reedland, Sandy was CEO of Pathways Diagnostics, Inc., a biomarker development company. Previously, from 1997 to 2003, Sandy was CFO of Bay City Capital, a merchant bank specializing in the biotech/life science industry, where he was responsible for oversight of the firm's finance department as well as President of the firm's M&A and financing division. From 1995 to 1997 Sandy was President and CFO of Epoch Biosciences, which was acquired by Nanogen in 2004. Previously, Sandy was a Certified Public Accountant for Coopers & Lybrand and held various investment banking positions focusing on biotech. Mr. Zweifach received his BA in Biology from UC San Diego and holds an MS in Human Physiology from UC Davis. ^ Return to Top


Jason E. Cohen Mr. Cohen joined Reedland Capital Partners in July of 1998. Previously, from 1995 until 1998, Jason was employed by Shoreline Pacific Institutional Finance of Sausalito, California as that firm’s Contracts Administrator. In this position, Jason facilitated the closing arrangements of over 50 private equity offerings, playing an instrumental role in the consummation of over $500 million of institutional investment in nationally-listed public companies, and working closely with the firm’s bankers, in-house legal counsel, client issuers, and investors. From 1991 through 1995, Jason was employed as a paralegal for a New York law firm specializing in bankruptcy/creditor rights, litigation and commercial law. Jason earned his undergraduate degree in Political Science from Colgate University in 1991. ^ Return to Top